Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toreforant Dose Finding Study in Active Rheumatoid Arthritis
NCT01679951Phase 2Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 2 trial of toreforant in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Oct 2012; status: terminated.
02
Drugs
toreforant
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01679951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01679951.